Immune checkpoint protein VISTA can directly turn off T-cells during immunotherapy, study finds

FHS
May 17, 2024
6:23 pm

A Cleveland Clinic-led team of scientists and physicians have discovered that the immune checkpoint protein VISTA can directly turn off tumor-fighting T-cells during immunotherapy and resist treatment.

Sticker Shock: Ophthalmic Bevacizumab Biosimilar Could Drive Up Costs

SEATTLE — Availability of a bevacizumab (Avastin) biosimilar for ophthalmic use could have the unintended consequence of driving up the cost of treating retinal disease

August 2, 2023

One year into 988 hotline, staff push for fixes to ambitious new system

One year after 988 launched as the new number for the national U.S. mental health hotline, the people behind the system say they’re still working

July 12, 2023

24 Key Trends Expected to Dominate HIMSS25 from Executives

The Healthcare Information and Management Systems Society (HIMSS) annual conference is upon us, and this year, the spotlight is firmly on AI. From automating administrative

February 25, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.